科伦药业：10月29日召开董事会会议

Group 1 - The core point of the article is that Kelun Pharmaceutical held its ninth meeting of the eighth board of directors on October 29, 2025, via telecommunication, where it reviewed the proposal to amend the "Board Secretary Work System" [1] - For the first half of 2025, Kelun Pharmaceutical's revenue composition was as follows: 89.66% from the pharmaceutical manufacturing industry, 7.01% from research and development projects, and 3.33% from other businesses [1] - As of the time of reporting, Kelun Pharmaceutical's market capitalization was 54.7 billion yuan [1]